Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignanciesDidier Blaise, Anne-Marie Stoppa, Laure Farnault et al.|Experimental Hematology|2010Cited by 39
Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative StudyAude Charbonnier, Mauricette Michallet, Carine Champigneulle et al.|Blood|2014Cited by 1
The Association Of Fludarabin, Oral Busulfan And Thymoglobulin Prior To Matched Related Allo-SCT Allows For High Long Term Outcome For Both Patients With Myeloid Or Lymphoid Malignancies: Long Term Analysis Of A Homogenous Cohort Of 100 Consecutive PatientsLaure Farnault, Didier Blaise, Benjamin Esterni et al.|Transplantation and Cellular Therapy|2010Cited by 0